STOCK TITAN

10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

10x Genomics (Nasdaq: TXG), a pioneer in single cell and spatial biology, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's management team is scheduled to present on Monday, January 13, at 7:30 a.m. Pacific Time.

The presentation will take the format of a fireside chat and will be accessible via live webcast through the 'Investors' section of 10x Genomics' website. For those unable to attend live, the webcast recording will remain available for replay for a minimum of 30 days following the event.

10x Genomics (Nasdaq: TXG), un pioniere nella biologia singola cellula e spaziale, ha annunciato la sua partecipazione alla 43ª Conferenza Annuale J.P. Morgan Healthcare. Il team dirigenziale dell'azienda presenterà lunedì 13 gennaio, alle 7:30 ora del Pacifico.

La presentazione avrà la forma di una chiacchierata informale e sarà accessibile tramite webcast in diretta nella sezione 'Investitori' del sito web di 10x Genomics. Per coloro che non potranno partecipare di persona, la registrazione del webcast rimarrà disponibile per la riproduzione per un minimo di 30 giorni dopo l'evento.

10x Genomics (Nasdaq: TXG), pionero en biología de célula única y espacial, ha anunciado su participación en la 43ª Conferencia Anual de J.P. Morgan Healthcare. El equipo de gestión de la compañía está programado para presentar el lunes 13 de enero, a las 7:30 a.m. hora del Pacífico.

La presentación tomará la forma de una charla informal y será accesible a través de un webcast en vivo en la sección 'Inversores' del sitio web de 10x Genomics. Para aquellos que no puedan asistir en vivo, la grabación del webcast estará disponible para reproducción durante un mínimo de 30 días después del evento.

10x Genomics (Nasdaq: TXG), 단일 세포 및 공간 생물학의 선구자, 제43회 JP 모건 헬스케어 컨퍼런스 참가를 발표했습니다. 회사 경영진 팀은 1월 13일 월요일, 태평양 표준시 기준 오전 7시 30분에 발표할 예정입니다.

발표는 포럼 형식으로 진행되며 10x Genomics 웹사이트의 '투자자' 섹션을 통해 실시간 웹캐스트로 접속할 수 있습니다. 실시간으로 참석할 수 없는 분들을 위해 웹캐스트 녹화는 이벤트 이후 최소 30일 동안 재생 가능합니다.

10x Genomics (Nasdaq: TXG), un pionnier dans la biologie des cellules uniques et spatiales, a annoncé sa participation à la 43e Conférence Annuelle J.P. Morgan Healthcare. L'équipe de direction de la société est prévue pour présenter le lundi 13 janvier à 7h30, heure du Pacifique.

La présentation prendra la forme d'une discussion informelle et sera accessible par webcast en direct dans la section 'Investisseurs' du site web de 10x Genomics. Pour ceux qui ne peuvent pas assister en direct, l'enregistrement du webcast restera disponible pour une lecture pendant un minimum de 30 jours après l'événement.

10x Genomics (Nasdaq: TXG), ein Pionier in der Einzelzellen- und Raumbiologie, hat die Teilnahme an der 43. jährlichen J.P. Morgan Healthcare-Konferenz bekannt gegeben. Das Management-Team des Unternehmens wird am Montag, den 13. Januar, um 7:30 Uhr Pazifische Zeit präsentieren.

Die Präsentation wird im Format eines Gesprächs stattfinden und kann über einen Live-Webcast im Bereich 'Investoren' der Website von 10x Genomics verfolgt werden. Für diejenigen, die nicht live teilnehmen können, bleibt die Aufzeichnung des Webcasts mindestens 30 Tage nach der Veranstaltung verfügbar.

Positive
  • None.
Negative
  • None.

PLEASANTON, Calif., Jan. 2, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 7:30 a.m. Pacific Time.

Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 30 days after the event.

About 10x Genomics

10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables, and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience, and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter)

Disclosure Information

10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.

Contacts

Investors: investors@10xgenomics.com

Media: media@10xgenomics.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302340408.html

SOURCE 10x Genomics, Inc.

FAQ

When is 10x Genomics (TXG) presenting at the J.P. Morgan Healthcare Conference 2025?

10x Genomics is scheduled to present on Monday, January 13, 2025, at 7:30 a.m. Pacific Time.

How can investors watch 10x Genomics' J.P. Morgan Healthcare Conference presentation?

Investors can watch the presentation via live webcast through the 'Investors' section of 10x Genomics' website at investors.10xgenomics.com.

How long will the TXG J.P. Morgan Conference presentation replay be available?

The webcast replay will be archived and available for at least 30 days after the event.

What type of presentation will TXG give at the J.P. Morgan Healthcare Conference?

The presentation will be in the format of a fireside chat with the management team.

10x Genomics, Inc.

NASDAQ:TXG

TXG Rankings

TXG Latest News

TXG Stock Data

1.89B
103.97M
2.16%
96.01%
5.1%
Health Information Services
Laboratory Analytical Instruments
Link
United States of America
PLEASANTON